Apolipoprotein A-IV inhibits experimental colitis

The antiatherogenic properties of apoA-IV suggest that this protein may act as an anti-inflammatory agent. We examined this possibility in a mouse model of acute colitis. Mice consumed 3% dextran sulfate sodium (DSS) in their drinking water for 7 days, with or without daily intraperitoneal injection...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Invest
Autors principals:	Vowinkel, Thorsten, Mori, Mikiji, Krieglstein, Christian F., Russell, Janice, Saijo, Fumito, Bharwani, Sulaiman, Turnage, Richard H., Davidson, W. Sean, Tso, Patrick, Granger, D. Neil, Kalogeris, Theodore J.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Clinical Investigation 2004
Matèries:	Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC450164/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15254593/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI21233
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!